首页 > 最新文献

Reproductive system & sexual disorders : current research最新文献

英文 中文
Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men. 克罗米芬柠檬酸盐能有效提高肥胖、年轻、性腺功能低下男性的睾酮水平。
Pub Date : 2015-11-13 DOI: 10.4172/2161-038X.1000155
S. Bendre, P. Murray, S. Basaria
BACKGROUNDObesity has been associated with low testosterone (T) in adult males and in pubertal boys. Therapy for hypogonadism with exogenous T may lead to testicular atrophy and later infertility. Only a few studies have demonstrated that the Selective Estrogen Receptor Modulator (SERM) clomiphene citrate (CC), an estrogen receptor antagonist, increases T in obese hypogonadal men while preventing testicular atrophy. No studies to date using CC have been done in younger obese post-pubertal hypogonadal males.OBJECTIVETo determine whether CC therapy is effective in increasing serum T levels in hypogonadal post-pubertal obese males 18-21 years.MATERIALS AND METHODSA retrospective chart analysis of records in obese men aged 18-21 years was done. Patients with early morning T level <350 ng/dl were given 25 mg CC on alternate days. Out of 18 patients found to have low T, 11 were analyzed. Baseline serum T, LH, FSH, weight and BMI were compared at baseline and after 3 months of CC treatment.RESULTSBaseline T level was 233 ± 66 ng/dl and increased to 581 ± 161 ng/dl (p<0.0001) after 3 months of CC treatment. Baseline LH levels increased from 3.3 ± 1.6 mIU/mL to 5.7 ± 1.7 mIU/mL (p=0.027). Similarly, baseline FSH levels increased from 2.8 ± 1.5 mIU/mL to 6.2 ± 3 mIU/mL after CC treatment (p=0.026). There was no correlation between baseline or post treatment weight or BMI and the T level, LH, or FSH level.CONCLUSIONThis is the first study reporting on CC therapy in obese, hypogonadal post-pubertal men 18-21 years. The SERM CC increased T in obese post-pubertal hypogonadal men, similar to efficacy of CC in adult hypogonadal men over the age 21 years. Larger randomized controlled studies to study the safety and potential use of CC to improve T in young obese HG men are needed.
背景:在成年男性和青春期男孩中,肥胖与低睾酮(T)有关。用外源性T治疗性腺功能减退可能导致睾丸萎缩和后来的不育。只有少数研究表明,选择性雌激素受体调节剂(SERM)克罗米芬柠檬酸盐(CC)是一种雌激素受体拮抗剂,可增加肥胖性腺功能低下男性的T,同时防止睾丸萎缩。到目前为止,还没有研究使用CC在青春期后性腺功能低下的年轻肥胖男性中进行。目的探讨CC治疗对提高18-21岁性腺功能低下的青春期后肥胖男性血清T水平是否有效。材料与方法对18 ~ 21岁男性肥胖患者进行回顾性图表分析。清晨T水平< 350ng /dl的患者隔天给予25mg CC。在发现的18例低T患者中,分析了11例。比较CC治疗前后3个月的基线血清T、LH、FSH、体重和BMI。结果基线T水平为233±66 ng/dl, CC治疗3个月后升高至581±161 ng/dl (p<0.0001)。基线LH水平从3.3±1.6 mIU/mL增加到5.7±1.7 mIU/mL (p=0.027)。同样,CC治疗后,基线FSH水平从2.8±1.5 mIU/mL增加到6.2±3 mIU/mL (p=0.026)。基线或治疗后体重或BMI与T水平、LH或FSH水平没有相关性。结论:本研究首次报道了18-21岁青春期后肥胖、性腺功能低下男性的CC治疗。SERM CC在青春期后性腺功能低下的肥胖男性中增加T,与CC在21岁以上性腺功能低下的成年男性中的效果相似。需要更大规模的随机对照研究来研究CC改善年轻肥胖HG男性T的安全性和潜在用途。
{"title":"Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men.","authors":"S. Bendre, P. Murray, S. Basaria","doi":"10.4172/2161-038X.1000155","DOIUrl":"https://doi.org/10.4172/2161-038X.1000155","url":null,"abstract":"BACKGROUND\u0000Obesity has been associated with low testosterone (T) in adult males and in pubertal boys. Therapy for hypogonadism with exogenous T may lead to testicular atrophy and later infertility. Only a few studies have demonstrated that the Selective Estrogen Receptor Modulator (SERM) clomiphene citrate (CC), an estrogen receptor antagonist, increases T in obese hypogonadal men while preventing testicular atrophy. No studies to date using CC have been done in younger obese post-pubertal hypogonadal males.\u0000\u0000\u0000OBJECTIVE\u0000To determine whether CC therapy is effective in increasing serum T levels in hypogonadal post-pubertal obese males 18-21 years.\u0000\u0000\u0000MATERIALS AND METHODS\u0000A retrospective chart analysis of records in obese men aged 18-21 years was done. Patients with early morning T level <350 ng/dl were given 25 mg CC on alternate days. Out of 18 patients found to have low T, 11 were analyzed. Baseline serum T, LH, FSH, weight and BMI were compared at baseline and after 3 months of CC treatment.\u0000\u0000\u0000RESULTS\u0000Baseline T level was 233 ± 66 ng/dl and increased to 581 ± 161 ng/dl (p<0.0001) after 3 months of CC treatment. Baseline LH levels increased from 3.3 ± 1.6 mIU/mL to 5.7 ± 1.7 mIU/mL (p=0.027). Similarly, baseline FSH levels increased from 2.8 ± 1.5 mIU/mL to 6.2 ± 3 mIU/mL after CC treatment (p=0.026). There was no correlation between baseline or post treatment weight or BMI and the T level, LH, or FSH level.\u0000\u0000\u0000CONCLUSION\u0000This is the first study reporting on CC therapy in obese, hypogonadal post-pubertal men 18-21 years. The SERM CC increased T in obese post-pubertal hypogonadal men, similar to efficacy of CC in adult hypogonadal men over the age 21 years. Larger randomized controlled studies to study the safety and potential use of CC to improve T in young obese HG men are needed.","PeriodicalId":21113,"journal":{"name":"Reproductive system & sexual disorders : current research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75810533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 23
Differential Expression of mRNA Encoding Cytokines and Chemokines in the Reproductive Tract after Infection of Mice with Chlamydia trachomatis 沙眼衣原体感染小鼠生殖道细胞因子和趋化因子mRNA的差异表达
Pub Date : 2015-09-01 DOI: 10.4172/2161-038X.1000152
K. L. Cerny, Maranda Van Fleet, Anatoly V. Slepenkin, E. Peterson, P. Bridges
Infection with Chlamydia trachomatis targets epithelial cells within the genital tract which respond by secreting chemokines and cytokines. Persistent inflammation can lead to fibrosis, tubal infertility and/or ectopic pregnancy; many infections are asymptomatic. Most studies have investigated the inflammatory response in the initial stages of infection, less is known about the later stages of infection, especially with a low, potentially asymptomatic, bacterial load. Our objective was to determine the inflammatory mediators involved in clearance of low-grade infection and the potential involvement in chronic inflammation. Six to eight week old C3H/HeJ mice were pretreated with 2.5 mg medroxyprogesterone acetate on day -10 and -3 before infection. Mice (n=3 for 28 d, n=3 for 35 d) were infected with 5 × 102 inclusion-forming units of C. trachomatis, serovar D; vaginal cultures were obtained weekly to monitor infection. Control mice (n=3 for 28 d, n=3 for 35 d) were sham infected. Mice were killed on day 28 (experiment 1) and day 35 (experiment 2) post-infection and vaginal tissue, uterine horns and oviducts collected for analysis of mRNAs encoding inflammatory cytokines and chemokines. Total RNA was isolated and a superarray analysis performed using mouse Cytokines and Chemokines PCR arrays (Qiagen, Valencia, CA). Statistical differences in gene expression were determined using a paired Students t-test. At 28 days after infection, the expression of mRNA encoding 6, 35 and 3 inflammatory genes differed from controls in vaginal, uterine and oviductal tissues, respectively (P<0.05). At 35 days after infection, the expression of mRNA encoding 16, 38 and 14 inflammatory genes differed from controls in vaginal, uterine and oviductal tissues, respectively (P<0.05). Understanding the mechanisms involved in the inflammatory response at later stages of infection should aid in the development of treatment options that minimize the development of asymptomatic, chronic inflammation-induced infertility.
沙眼衣原体感染的目标是生殖道内的上皮细胞,其反应是分泌趋化因子和细胞因子。持续的炎症可导致纤维化、输卵管不孕和/或异位妊娠;许多感染是无症状的。大多数研究都研究了感染初期的炎症反应,但对感染后期,特别是低水平、可能无症状的细菌载量,了解较少。我们的目的是确定参与清除低级别感染的炎症介质和慢性炎症的潜在参与。6 ~ 8周龄C3H/HeJ小鼠在感染前第10天和第3天分别给予2.5 mg醋酸甲孕酮预处理。小鼠(n=3, 28 d, n=3, 35 d)感染5 × 102个包涵体单位沙眼衣原体,血清型d;每周进行阴道培养以监测感染情况。对照小鼠(n=3只,28 d, n=3只,35 d)进行假感染。在感染后第28天(实验1)和第35天(实验2)处死小鼠,收集阴道组织、子宫角和输卵管,分析编码炎症细胞因子和趋化因子的mrna。分离总RNA,并使用小鼠细胞因子和趋化因子PCR阵列(Qiagen, Valencia, CA)进行超阵列分析。使用配对学生t检验确定基因表达的统计差异。感染后28 d,阴道、子宫和输卵管组织中编码6、35和3个炎症基因的mRNA表达量分别高于对照组(P<0.05)。感染后35 d,阴道、子宫和输卵管组织中编码16、38和14个炎症基因的mRNA表达量分别高于对照组(P<0.05)。了解感染后期炎症反应的机制应该有助于制定治疗方案,最大限度地减少无症状慢性炎症性不孕的发展。
{"title":"Differential Expression of mRNA Encoding Cytokines and Chemokines in the Reproductive Tract after Infection of Mice with Chlamydia trachomatis","authors":"K. L. Cerny, Maranda Van Fleet, Anatoly V. Slepenkin, E. Peterson, P. Bridges","doi":"10.4172/2161-038X.1000152","DOIUrl":"https://doi.org/10.4172/2161-038X.1000152","url":null,"abstract":"Infection with Chlamydia trachomatis targets epithelial cells within the genital tract which respond by secreting chemokines and cytokines. Persistent inflammation can lead to fibrosis, tubal infertility and/or ectopic pregnancy; many infections are asymptomatic. Most studies have investigated the inflammatory response in the initial stages of infection, less is known about the later stages of infection, especially with a low, potentially asymptomatic, bacterial load. Our objective was to determine the inflammatory mediators involved in clearance of low-grade infection and the potential involvement in chronic inflammation. Six to eight week old C3H/HeJ mice were pretreated with 2.5 mg medroxyprogesterone acetate on day -10 and -3 before infection. Mice (n=3 for 28 d, n=3 for 35 d) were infected with 5 × 102 inclusion-forming units of C. trachomatis, serovar D; vaginal cultures were obtained weekly to monitor infection. Control mice (n=3 for 28 d, n=3 for 35 d) were sham infected. Mice were killed on day 28 (experiment 1) and day 35 (experiment 2) post-infection and vaginal tissue, uterine horns and oviducts collected for analysis of mRNAs encoding inflammatory cytokines and chemokines. Total RNA was isolated and a superarray analysis performed using mouse Cytokines and Chemokines PCR arrays (Qiagen, Valencia, CA). Statistical differences in gene expression were determined using a paired Students t-test. At 28 days after infection, the expression of mRNA encoding 6, 35 and 3 inflammatory genes differed from controls in vaginal, uterine and oviductal tissues, respectively (P<0.05). At 35 days after infection, the expression of mRNA encoding 16, 38 and 14 inflammatory genes differed from controls in vaginal, uterine and oviductal tissues, respectively (P<0.05). Understanding the mechanisms involved in the inflammatory response at later stages of infection should aid in the development of treatment options that minimize the development of asymptomatic, chronic inflammation-induced infertility.","PeriodicalId":21113,"journal":{"name":"Reproductive system & sexual disorders : current research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91400144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Role of Male Factor Testing in Recurrent Pregnancy Loss or In Vitro Fertilization Failure. 男性因素检测在复发性妊娠丢失或体外受精失败中的作用。
Pub Date : 2015-01-01 DOI: 10.4172/2161-038X.1000e122
Ryan Dickey, Ranjith Ramasamy
The appropriate management for male partners of couples with recurrent pregnancy loss (RPL) or recurrent implantation failure during in vitro fertilization (IVF) remains unclear. In particular, men with normal semen parameters are often ignored because the “bulk semen parameters” appear normal [1]. Despite normal semen parameters, male partners in couples with RPL or recurrent implantation failure could have underlying genetic abnormalities in sperm DNA that can be identified. There are a couple of diagnostic tests that we recommend in the evaluation of these men, the first being DNA Fragmentation Index (DFI) and the second, fluorescence in situ hybridization (FISH) for evaluating sperm aneuploidy.
{"title":"Role of Male Factor Testing in Recurrent Pregnancy Loss or <i>In Vitro</i> Fertilization Failure.","authors":"Ryan Dickey,&nbsp;Ranjith Ramasamy","doi":"10.4172/2161-038X.1000e122","DOIUrl":"https://doi.org/10.4172/2161-038X.1000e122","url":null,"abstract":"The appropriate management for male partners of couples with recurrent pregnancy loss (RPL) or recurrent implantation failure during in vitro fertilization (IVF) remains unclear. In particular, men with normal semen parameters are often ignored because the “bulk semen parameters” appear normal [1]. Despite normal semen parameters, male partners in couples with RPL or recurrent implantation failure could have underlying genetic abnormalities in sperm DNA that can be identified. There are a couple of diagnostic tests that we recommend in the evaluation of these men, the first being DNA Fragmentation Index (DFI) and the second, fluorescence in situ hybridization (FISH) for evaluating sperm aneuploidy.","PeriodicalId":21113,"journal":{"name":"Reproductive system & sexual disorders : current research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2161-038X.1000e122","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34117349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Should Men Take Prenatal Vitamins? 男性应该服用产前维生素吗?
Pub Date : 2014-07-01 DOI: 10.4172/2161-038X.1000139
Jason M Scovell, Ranjith Ramasamy
Congenital abnormalities are the leading cause of infant mortalities in the United States (25%) and across the world [1]. Public health interventions have included reducing maternal disease, prenatal care of mothers, reduction of exposure to teratogens (agent that can disturb the development of an embryo or fetus), and nutritional interventions [2]. Potentially the most significant nutritional intervention has been the prenatal supplementation of folate, which has been shown to reduce the incidence of neural tube defects [3], limb malformations, urogenital abnormalities, cardiovascular malformations [4], and cleft lip or palate [5].
{"title":"Should Men Take Prenatal Vitamins?","authors":"Jason M Scovell,&nbsp;Ranjith Ramasamy","doi":"10.4172/2161-038X.1000139","DOIUrl":"https://doi.org/10.4172/2161-038X.1000139","url":null,"abstract":"Congenital abnormalities are the leading cause of infant mortalities in the United States (25%) and across the world [1]. Public health interventions have included reducing maternal disease, prenatal care of mothers, reduction of exposure to teratogens (agent that can disturb the development of an embryo or fetus), and nutritional interventions [2]. Potentially the most significant nutritional intervention has been the prenatal supplementation of folate, which has been shown to reduce the incidence of neural tube defects [3], limb malformations, urogenital abnormalities, cardiovascular malformations [4], and cleft lip or palate [5].","PeriodicalId":21113,"journal":{"name":"Reproductive system & sexual disorders : current research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2161-038X.1000139","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33123123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protein acetylation and spermatogenesis. 蛋白质乙酰化与精子发生。
Pub Date : 2013-06-03 DOI: 10.4172/2161-038x.s1-005
Aly Pang, Om Rennert

Spermatogenesis refers to the developmental process of male germ cell formation from the spermatogonial stem cell to mature spermatozoa. The progression of male germ cells through the different phases of development, along with changes in cellular size and morphology, involves a coordinated change in their gene expression program at both the transcript and protein levels. It is well known that the stability, biological activity and cellular localization of proteins are regulated by post-translational modifications. In this review, we provide a brief update of current knowledge about the role of protein acetylation in mammalian spermatogenesis. Based on recent findings specific examples were cited to illustrate how these modifications are involved in controlling the different events that are important to the proper development of male germ cells.

精子发生是指从原精子干细胞到成熟精子形成雄性生殖细胞的发育过程。男性生殖细胞在不同发育阶段的进展,以及细胞大小和形态的变化,涉及其基因表达程序在转录物和蛋白质水平上的协调变化。众所周知,蛋白质的稳定性、生物活性和细胞定位受翻译后修饰的调控。在这篇综述中,我们简要介绍了目前关于蛋白质乙酰化在哺乳动物精子发生中的作用的最新知识。根据最近的发现,具体的例子被引用来说明这些修饰是如何参与控制对男性生殖细胞正常发育重要的不同事件的。
{"title":"Protein acetylation and spermatogenesis.","authors":"Aly Pang,&nbsp;Om Rennert","doi":"10.4172/2161-038x.s1-005","DOIUrl":"https://doi.org/10.4172/2161-038x.s1-005","url":null,"abstract":"<p><p>Spermatogenesis refers to the developmental process of male germ cell formation from the spermatogonial stem cell to mature spermatozoa. The progression of male germ cells through the different phases of development, along with changes in cellular size and morphology, involves a coordinated change in their gene expression program at both the transcript and protein levels. It is well known that the stability, biological activity and cellular localization of proteins are regulated by post-translational modifications. In this review, we provide a brief update of current knowledge about the role of protein acetylation in mammalian spermatogenesis. Based on recent findings specific examples were cited to illustrate how these modifications are involved in controlling the different events that are important to the proper development of male germ cells.</p>","PeriodicalId":21113,"journal":{"name":"Reproductive system & sexual disorders : current research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201854/pdf/nihms502618.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32761041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Association of Age at Menarche and Menstrual Characteristics with Adult Onset Asthma among Reproductive Age Women. 初潮年龄和月经特征与育龄妇女成年后哮喘的关系。
Pub Date : 2012-08-31 DOI: 10.4172/2161-038X.1000111
Neway G Fida, Michelle A Williams, Daniel A Enquobahrie

Background: Observations of increasing asthma incidence, decreasing age at menarche, and common risk factors have led investigators to hypothesize potential associations of age at menarche or menstrual characteristics with incidence of adult onset asthma. We evaluated these associations among reproductive age women.

Methods: Study participants were selected from among women enrolled in a pregnancy cohort study. Information on age at menarche, menstrual characteristics, and history of asthma was collected using interviewer-administered questionnaires. Adult onset asthma was defined as asthma first diagnosed after onset of menarche. Women who had no information on asthma and menstrual history and those who were diagnosed with asthma before menarche were excluded. A total of 3,461 women comprised the analytic population. Logistic regression was used to estimate adjusted relative risk (aRR) and 95% confidence intervals (95% CI) relating age at menarche and menstrual characteristics with adult onset asthma.

Results: Mean age at menarche was 12.8 years (standard deviation=1.46). Among study participants, 7.5% were diagnosed with asthma after the onset of menarche. After controlling for potential confounders (age, race, body mass index, and socio-economic status), women who had early menarche (<12 years old) had 60% higher risk of being diagnosed with adult onset asthma as compared with women who did not have early menarche (≥ 12 years old) (aRR= 1.59, 95% CI 1.19 - 2.13). Menstrual irregularities or abnormal (short or long) cycle length were not associated with risk of adult onset asthma. In addition, no significant interaction was observed between age at menarche or menstrual characteristics with body mass index or physical activity (in adolescence) in relation to adult onset asthma.

Conclusion: Early menarche is associated with a higher risk of developing adult onset asthma among reproductive age women. Mechanisms for this association are potential areas of future research.

背景:哮喘发病率的增加、月经初潮年龄的降低以及常见的风险因素导致研究人员假设月经初潮年龄或月经特征与成人哮喘发病率可能存在关联。我们对育龄妇女的这些关联进行了评估:方法:我们从参加妊娠队列研究的妇女中选取了研究对象。研究人员通过访谈问卷收集了有关初潮年龄、月经特征和哮喘病史的信息。成人哮喘的定义是月经初潮后首次诊断出的哮喘。没有提供哮喘和月经史资料的妇女以及在月经初潮前被诊断患有哮喘的妇女被排除在外。分析人群中共有 3461 名女性。采用逻辑回归法估算了月经初潮年龄和月经特征与成年哮喘发病的调整相对风险(aRR)和 95% 置信区间(95% CI):月经初潮的平均年龄为 12.8 岁(标准差=1.46)。在研究参与者中,7.5%的人在初潮后被诊断出患有哮喘。在对潜在的混杂因素(年龄、种族、体重指数和社会经济地位)进行控制后,初潮过早的女性(结论:初潮过早与哮喘的发生有关:初潮过早与育龄妇女罹患成人哮喘的风险较高有关。这种关联的机制是未来研究的潜在领域。
{"title":"Association of Age at Menarche and Menstrual Characteristics with Adult Onset Asthma among Reproductive Age Women.","authors":"Neway G Fida, Michelle A Williams, Daniel A Enquobahrie","doi":"10.4172/2161-038X.1000111","DOIUrl":"10.4172/2161-038X.1000111","url":null,"abstract":"<p><strong>Background: </strong>Observations of increasing asthma incidence, decreasing age at menarche, and common risk factors have led investigators to hypothesize potential associations of age at menarche or menstrual characteristics with incidence of adult onset asthma. We evaluated these associations among reproductive age women.</p><p><strong>Methods: </strong>Study participants were selected from among women enrolled in a pregnancy cohort study. Information on age at menarche, menstrual characteristics, and history of asthma was collected using interviewer-administered questionnaires. Adult onset asthma was defined as asthma first diagnosed after onset of menarche. Women who had no information on asthma and menstrual history and those who were diagnosed with asthma before menarche were excluded. A total of 3,461 women comprised the analytic population. Logistic regression was used to estimate adjusted relative risk (aRR) and 95% confidence intervals (95% CI) relating age at menarche and menstrual characteristics with adult onset asthma.</p><p><strong>Results: </strong>Mean age at menarche was 12.8 years (standard deviation=1.46). Among study participants, 7.5% were diagnosed with asthma after the onset of menarche. After controlling for potential confounders (age, race, body mass index, and socio-economic status), women who had early menarche (<12 years old) had 60% higher risk of being diagnosed with adult onset asthma as compared with women who did not have early menarche (≥ 12 years old) (aRR= 1.59, 95% CI 1.19 - 2.13). Menstrual irregularities or abnormal (short or long) cycle length were not associated with risk of adult onset asthma. In addition, no significant interaction was observed between age at menarche or menstrual characteristics with body mass index or physical activity (in adolescence) in relation to adult onset asthma.</p><p><strong>Conclusion: </strong>Early menarche is associated with a higher risk of developing adult onset asthma among reproductive age women. Mechanisms for this association are potential areas of future research.</p>","PeriodicalId":21113,"journal":{"name":"Reproductive system & sexual disorders : current research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192656/pdf/nihms578531.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32743111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Genetics of Keratoconus: A Review. 圆锥角膜的遗传学研究进展。
Pub Date : 2012-06-03 DOI: 10.4172/2161-038X.S6-001
Joshua Wheeler, Michael A Hauser, Natalie A Afshari, R Rand Allingham, Yutao Liu

Keratoconus is the most common ectatic disorder of the corneal. Genetic and environmental factors may contribute to its pathogenesis. The focus of this article is to summarize current research into the complex genetics of keratoconus. We discuss the evidence of genetic etiology including family-based linkage studies, twin studies, genetic mutations, and genome-wide association studies. The genes implicated potentially include VSX1, miR-184, DOCK9, SOD1, RAB3GAP1, and HGF. Besides the coding mutations, we also highlight the potential contribution of DNA copy number variants in the pathogenesis of keratoconus. Finally, we present future directions for genetic research in the understanding of the complex genetics of keratoconus and its clinical significance. As new functional, candidate genes for keratoconus are being discovered at a rapid pace, the molecular genetic mechanisms underlying keratoconus pathogenesis will advance our understanding of keratoconus and promote the development of a novel therapy.

圆锥角膜是最常见的角膜膨胀性疾病。遗传和环境因素可能导致其发病。本文就圆锥角膜复杂遗传学的研究现状作一综述。我们讨论了遗传病因学的证据,包括基于家庭的连锁研究、双胞胎研究、基因突变和全基因组关联研究。可能涉及的基因包括VSX1、miR-184、DOCK9、SOD1、RAB3GAP1和HGF。除了编码突变,我们还强调了DNA拷贝数变异在圆锥角膜发病机制中的潜在贡献。最后,对圆锥角膜复杂遗传学的认识及其临床意义提出了今后的遗传学研究方向。随着新的功能性候选圆锥角膜基因的快速发现,圆锥角膜发病机制的分子遗传机制将促进我们对圆锥角膜的认识,并促进新的治疗方法的发展。
{"title":"The Genetics of Keratoconus: A Review.","authors":"Joshua Wheeler,&nbsp;Michael A Hauser,&nbsp;Natalie A Afshari,&nbsp;R Rand Allingham,&nbsp;Yutao Liu","doi":"10.4172/2161-038X.S6-001","DOIUrl":"https://doi.org/10.4172/2161-038X.S6-001","url":null,"abstract":"<p><p>Keratoconus is the most common ectatic disorder of the corneal. Genetic and environmental factors may contribute to its pathogenesis. The focus of this article is to summarize current research into the complex genetics of keratoconus. We discuss the evidence of genetic etiology including family-based linkage studies, twin studies, genetic mutations, and genome-wide association studies. The genes implicated potentially include <i>VSX1</i>, <i>miR-184</i>, <i>DOCK9</i>, <i>SOD1</i>, <i>RAB3GAP1,</i> and <i>HGF.</i> Besides the coding mutations, we also highlight the potential contribution of DNA copy number variants in the pathogenesis of keratoconus. Finally, we present future directions for genetic research in the understanding of the complex genetics of keratoconus and its clinical significance. As new functional, candidate genes for keratoconus are being discovered at a rapid pace, the molecular genetic mechanisms underlying keratoconus pathogenesis will advance our understanding of keratoconus and promote the development of a novel therapy.</p>","PeriodicalId":21113,"journal":{"name":"Reproductive system & sexual disorders : current research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2161-038X.S6-001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31621948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 72
Localization of C-Fos-Induced Growth Factor (Figf) mRNA Expression in the Mouse Uterus during Implantation c - fos诱导生长因子(Figf) mRNA在小鼠子宫着床过程中的表达定位
Pub Date : 2012-01-25 DOI: 10.4172/2161-038X.S1-003
Charles A. Scott, Kirsten Eckstrum, B. Bany
The purpose of this study was to characterize the localization of Figf mRNA in the mouse uterus during embryo implantation. Strong Figf mRNA hybridization signals were seen in the primary decidual zone just after the onset of implantation from Days 4.5–6.5. On Day 7.5, this expression continued around the concept us, but in addition we observed high expression of Figf mRNA in the endothelial cells that line the forming vascular sinusoids in the lateral me some trial decidua. Interestingly, on Days 8.5 this high expression continued in the endothelial cells of sinusoids in the lateral me some trial decidual tissue but not in the decidual cells surrounding the concept us. As implantation and placental development finished, Figf mRNA expression remained in the endothelial cells of the sinusoids and spiral arterioles of the decidua basalis. Interestingly, Flt4 mRNA was localized to the endothelial cells lining the sinusoids that form during implantation. Since the endothelial cells of the me some trial sinusoids exhibit a high level of proliferation, we speculate that FIGF-FLT4 signaling may play a role in their formation and function during implantation. This work will provide a basis for further research on the potential role of FIGF-FLT4 signaling in endometrial angiogenesis during implantation in mice.
本研究的目的是表征胚胎着床过程中Figf mRNA在小鼠子宫中的定位。在着床后的第4.5-6.5天,在初级蜕膜区可见到强烈的Figf mRNA杂交信号。在第7.5天,这种表达继续围绕着我们的概念,但除此之外,我们还观察到在一些蜕膜外侧形成血管窦的内皮细胞中Figf mRNA的高表达。有趣的是,在第8.5天,这种高表达继续在侧壁的一些试验蜕膜组织的窦内皮细胞中存在,但在概念膜周围的蜕膜细胞中没有。随着胚胎着床和胎盘发育完成,基底蜕膜窦状动脉和螺旋小动脉内皮细胞中仍有Figf mRNA的表达。有趣的是,Flt4 mRNA定位于植入过程中形成的窦状体内皮细胞。由于一些试验窦的内皮细胞表现出高水平的增殖,我们推测FIGF-FLT4信号可能在其植入过程中的形成和功能中发挥作用。本工作将为进一步研究FIGF-FLT4信号在小鼠着床过程中子宫内膜血管生成中的潜在作用提供基础。
{"title":"Localization of C-Fos-Induced Growth Factor (Figf) mRNA Expression in the Mouse Uterus during Implantation","authors":"Charles A. Scott, Kirsten Eckstrum, B. Bany","doi":"10.4172/2161-038X.S1-003","DOIUrl":"https://doi.org/10.4172/2161-038X.S1-003","url":null,"abstract":"The purpose of this study was to characterize the localization of Figf mRNA in the mouse uterus during embryo implantation. Strong Figf mRNA hybridization signals were seen in the primary decidual zone just after the onset of implantation from Days 4.5–6.5. On Day 7.5, this expression continued around the concept us, but in addition we observed high expression of Figf mRNA in the endothelial cells that line the forming vascular sinusoids in the lateral me some trial decidua. Interestingly, on Days 8.5 this high expression continued in the endothelial cells of sinusoids in the lateral me some trial decidual tissue but not in the decidual cells surrounding the concept us. As implantation and placental development finished, Figf mRNA expression remained in the endothelial cells of the sinusoids and spiral arterioles of the decidua basalis. Interestingly, Flt4 mRNA was localized to the endothelial cells lining the sinusoids that form during implantation. Since the endothelial cells of the me some trial sinusoids exhibit a high level of proliferation, we speculate that FIGF-FLT4 signaling may play a role in their formation and function during implantation. This work will provide a basis for further research on the potential role of FIGF-FLT4 signaling in endometrial angiogenesis during implantation in mice.","PeriodicalId":21113,"journal":{"name":"Reproductive system & sexual disorders : current research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82468767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Differential Expression of HrtA1 and ADAM12 in Placentas from Preeclamptic and Normotensive Pregnancies. HrtA1和ADAM12在子痫前期和正常妊娠胎盘中的差异表达
Pub Date : 2012-01-01 DOI: 10.4172/2161-038X.1000110
Daniel A Enquobahrie, Karin Hevner, Chunfang Qiu, Dejene F Abetew, Tanya K Sorensen, Michelle A Williams

Background: High temperature requirement factor A 1 (HtrA1) and a disintegrin and metalloproteinase 12 (ADAM12), which play roles in placental implantation and placental growth, have been implicated in the pathogenesis of preeclampsia.

Methods: We investigated relative mRNA expression of both genes in placental tissues from women with preeclampsia (N=18) (average gestational age 36 weeks) and an equal number of women with normotensive pregnancies (average gestational age 39 weeks). Real-time polymerase chain reaction was used to measure mRNA extracted from term placental biopsies. Differential gene expression was evaluated using Student's T-test and fold change analyses.

Results: Statistically significant increases in placental HtRA1 (1.69-fold, p=0.030) and ADAM12 (1.48-fold, p=0.010) mRNA expression were observed among preeclamptic cases as compared with normotensive controls. HtrA1 expression was correlated with maternal age (p-value <0.01) among preeclampsia cases.

Conclusion: Increases in HtRA1 and ADAM12 placental gene expression in placentas from preeclamptic pregnancies are consistent with some earlier reports of altered serum protein concentrations in preeclamptic pregnancies. This adds to the literature suggesting that defects in placentation (e.g. involving trophoblast invasion) are of etiologic importance in preeclampsia.

背景:高温需要因子a1 (HtrA1)和崩解素和金属蛋白酶12 (ADAM12)在胎盘着床和胎盘生长过程中发挥重要作用,与子痫前期的发病机制有关。方法:我们研究了这两个基因在子痫前期妇女(N=18)(平均胎龄36周)和同等数量的正常妊娠妇女(平均胎龄39周)胎盘组织中的相对mRNA表达。实时聚合酶链反应测定足月胎盘活检提取的mRNA。差异基因表达评估采用学生t检验和折叠变化分析。结果:与正常血压对照组相比,子痫前期患者胎盘HtRA1(1.69倍,p=0.030)和ADAM12(1.48倍,p=0.010) mRNA表达显著升高。结论:子痫前期胎盘中HtrA1和ADAM12胎盘基因表达的增加与早期一些子痫前期血清蛋白浓度改变的报道一致。这增加了文献提示胎盘缺陷(例如涉及滋养细胞侵袭)在子痫前期的病因学重要性。
{"title":"Differential Expression of HrtA1 and ADAM12 in Placentas from Preeclamptic and Normotensive Pregnancies.","authors":"Daniel A Enquobahrie,&nbsp;Karin Hevner,&nbsp;Chunfang Qiu,&nbsp;Dejene F Abetew,&nbsp;Tanya K Sorensen,&nbsp;Michelle A Williams","doi":"10.4172/2161-038X.1000110","DOIUrl":"https://doi.org/10.4172/2161-038X.1000110","url":null,"abstract":"<p><strong>Background: </strong>High temperature requirement factor A 1 (HtrA1) and a disintegrin and metalloproteinase 12 (ADAM12), which play roles in placental implantation and placental growth, have been implicated in the pathogenesis of preeclampsia.</p><p><strong>Methods: </strong>We investigated relative mRNA expression of both genes in placental tissues from women with preeclampsia (N=18) (average gestational age 36 weeks) and an equal number of women with normotensive pregnancies (average gestational age 39 weeks). Real-time polymerase chain reaction was used to measure mRNA extracted from term placental biopsies. Differential gene expression was evaluated using Student's T-test and fold change analyses.</p><p><strong>Results: </strong>Statistically significant increases in placental HtRA1 (1.69-fold, p=0.030) and ADAM12 (1.48-fold, p=0.010) mRNA expression were observed among preeclamptic cases as compared with normotensive controls. HtrA1 expression was correlated with maternal age (p-value <0.01) among preeclampsia cases.</p><p><strong>Conclusion: </strong>Increases in HtRA1 and ADAM12 placental gene expression in placentas from preeclamptic pregnancies are consistent with some earlier reports of altered serum protein concentrations in preeclamptic pregnancies. This adds to the literature suggesting that defects in placentation (e.g. involving trophoblast invasion) are of etiologic importance in preeclampsia.</p>","PeriodicalId":21113,"journal":{"name":"Reproductive system & sexual disorders : current research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031672/pdf/nihms-578447.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32369627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
期刊
Reproductive system & sexual disorders : current research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1